Newsroom | 10714 results

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a leader in organ transplant technologies and services, today announced the successful completion of its hundredth case using the FDA-cleared KidneyVault™ Portable Renal Perfusion System. This milestone was achieved with the support of Tennessee Donor Services (TDS), an Organ Procurement Organization (OPO) that serves more than 6 million people across Tennessee and Virginia. In recent years, the transplantation industry has removed geogra...

CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April 28, 2025. In this role, Beth will lead the commercial organization, including preparing for the U.S. launch of ENCELTOTM (revakinagene taroretcel-lwey), the first and only approved treatment for adults with idiopathic Macular Telangiectasia Type 2...

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC’s PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. “PTP Corpectomy represents a signific...

CAIRO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves. For more than 65 years, Edwards has been the leader in heart valve innovations. To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two d...

ABU DHABI, Emirati Arabi Uniti--(BUSINESS WIRE)--Abu Dhabi ha lanciato l'innovativo cluster dedicato al settore delle scienze della vita, rafforzando la sua posizione di hub globale per la biotecnologia, la tecnologia medica e la sanità digitale. Sviluppato dal Dipartimento per lo Sviluppo Economico di Abu Dhabi, dall'Ufficio per gli Investimenti di Abu Dhabi (ADIO) e dal Dipartimento della Salute di Abu Dhabi, il cluster HELM (Health, Endurance, Longevity, and Medicine) è stato progettato per...

ABU DHABI, Verenigde Arabische Emiraten--(BUSINESS WIRE)--Abu Dhabi heeft het baanbrekende life sciences-cluster gelanceerd, waardoor de positie van het land als een wereldwijde hub voor biotechnologie, MedTech en digitale gezondheid wordt versterkt. Het Health, Endurance, Longevity and Medicine (HELM)-cluster is ontwikkeld door het Abu Dhabi Department of Economic Development, Abu Dhabi Investment Office (ADIO) en het Department of Health – Abu Dhabi, en is ontworpen om innovatie in de gezondh...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies is implementing efficiency measures for CyPath Lung that streamline lab processing and data acquisition and reduce lab costs....

DUBLIN--(BUSINESS WIRE)--The "Augmented Reality Surgical Systems Market by Component, by Device Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering In a transformative move for surgical interventions, the global augmented reality (AR) surgical systems market size was valued at USD 2.61 billion in 2023 and is expected to ascend to an impressive USD 17.04 billion by 2034. This robust growth, at a CAGR of 40.84% from 2024 to 2034, illustrate...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 4:30 pm (Local Time -PST). Brent Ashton, Covalon’s CEO will review why Covalon is in the “sweet spot” in the microcap sector as an undervalued, cash rich, profitable healthcare compa...

アラブ首長国連邦、アブダビ--(BUSINESS WIRE)--（ビジネスワイヤ） -- アブダビは、バイオテクノロジー、医療技術、デジタルヘルスの分野で世界的ハブとしての地位を強化するため、革新的なライフサイエンス・クラスターを立ち上げました。アブダビ経済開発省、アブダビ投資局（ADIO）、およびアブダビ保健省によって発足された健康・持久力・長寿・医療（HELM）クラスターは、医療イノベーションの推進、国際的な投資の誘致、そして世界中の人々へ持続的な恩恵を提供することを目的としています。 アブダビ・グローバル・ヘルス・ウィークの期間中に発表されたHELMクラスターは、先進的なヘルスケアおよびライフサイエンス・ソリューションの研究、開発、製造、商業化のためのプラットフォームとして機能します。世界中の企業はこのクラスターによって、AIによる診断や医薬品製造から遺伝子治療や精密医療に至るまで、革新的な科学技術をスケーラブルでアクセス可能な患者中心のソリューションへと転換することが可能になります。 世界水準のインフラ、先進的な規制環境、戦略的な地理的立地を備えたアブダビは、世界市場への比類...